Description-The percentage of members 18 years of age and older during the measurement year who were hospitalized and discharged from July 1 of the year prior to the measurement year to June 30 of the measurement year with a diagnosis of AMI and who received persistent beta-blocker treatment for six months after discharge.


Denominator-The eligible population. 18 years and older as of December 31 of the measurement year.

Denominator Exclusions or Exceptions (when applicable)-Asthma, COPD, Allergy to BB RX

Numerator-A 180-day course of treatment with beta-blockers